Dr. Bashir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
210 N Hammes Ave
Ste 110
Joliet, IL 60435Phone+1 815-582-3026Fax+1 815-582-3025
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Rheumatology, 2007 - 2009
- University of TennesseeResidency, Internal Medicine, 2004 - 2007
- Aga Khan Medical CollegeClass of 2002
Certifications & Licensure
- IL State Medical License 2019 - 2026
- MO State Medical License 2009 - 2025
- WI State Medical License 2021 - 2025
- OH State Medical License 2020 - 2022
- IN State Medical License 2019 - 2021
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Evaluation 2% Chlorhexidine Gluconate Start of enrollment: 2016 Nov 16
Publications & Presentations
PubMed
- 3 citationsAn unusual case of cerebellar hemorrhage in a patient with systemic lupus erythematosus.Hamid Bashir, Prabha Ranganathan
Arthritis Care & Research. 2010-05-01 - 19 citationsCisplatin-induced hypomagnesemia and cardiac dysrhythmia.Hamid Bashir, Debbie Crom, Monika L. Metzger, Jean Mulcahey, Deborah P. Jones
Pediatric Blood & Cancer. 2007-11-01 - 18 citationsPericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients.Hamid Bashir, Melissa M. Hudson, Sue C. Kaste, Scott C. Howard, Matthew J. Krasin
Pediatric Blood & Cancer. 2007-10-15
Press Mentions
- Preparation and Nanoencapsulation of Lectin from Lepidium Sativum on Chitosan-Tripolyphosphate Nanoparticle and Their Cytotoxicity Against Hepatocellular Carcinoma Cells (HepG2)October 22nd, 2020
- Preparation and Nanoencapsulation of Lectin from Lepidium Sativum on Chitosan-Tripolyphosphate Nanoparticle and Their Cytotoxicity Against Hepatocellular Carcinoma Cells (HepG2)October 22nd, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: